TMCnet - World's Largest Communications and Technology Community



NGSX, SCR, EXH, TRGT, AEV, CHLN Are Seasonally Ripe To Go Down In the Next Five Weeks
[November 09, 2012]

NGSX, SCR, EXH, TRGT, AEV, CHLN Are Seasonally Ripe To Go Down In the Next Five Weeks

Nov 09, 2012 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET / is monitoring the Seasonality of NeurogesX Inc (NASDAQ:NGSX), Score Media Inc (NYSE:SCR), Exterran Holdings Inc (NYSE:EXH), Targacept Inc (NASDAQ:TRGT), AEGON N.V. 6.875% Perpetual Capital Securities (NYSE:AEV), China Housing & Land Development Inc (NASDAQ:CHLN) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: The following stocks are expected to go Down: Symbol Company Expected Return Odds By The Following Date NGSX NeurogesX Inc -6.29% 100.00% (5 of 5) Friday, December 7th 2012 SCR Score Media Inc -7.74% 100.00% (5 of 5) Tuesday, November 20th 2012 EXH Exterran Holdings Inc -4.25% 100.00% (5 of 5) Tuesday, November 27th 2012 TRGT Targacept Inc -3.81% 100.00% (6 of 6) Tuesday, November 13th 2012 AEV AEGON N.V. 6.875% Perpetual Capital Securities -4.41% 100.00% (6 of 6) Thursday, November 29th 2012 CHLN China Housing & Land Development Inc -9.70% 100.00% (6 of 6) Thursday, December 20th 2012 NeurogesX Inc (NASDAQ:NGSX) - NeurogesX, Inc., a biopharmaceutical company, focuses on developing and commercializing novel pain management therapies. The company's lead product includes Qutenza (capsaicin) 8% patch, a non-narcotic analgesic formulated dermal delivery system containing an 8% concentration of synthetic capsaicin. Capsaicin is released from the patch and, with the aid of penetration enhancers, penetrates into the skin during application without significant absorption of capsaicin into the bloodstream. Its Qutenza has been approved by the U.S, Food and Drug Administration for the management of neuropathic pain associated with postherpetic neuralgia; and approved in the European Union for the treatment of peripheral neuropathic pain in non-diabetic adults, either alone or in combination with other medicinal products for pain. The company's early stage product pipeline includes NGX-1998, a topical liquid formulation of capsaicin for potential use in neuropathic pain conditions; NGX-1576, NGX-9674, and NGX-5752 prodrugs of acetaminophen for potential use in acute pain, including traumatic pain, post-surgical pain, and fever; and NGX-6052, an opioid prodrug for potential use in chronic pain indications. The company was formerly known as Advanced Analgesics, Inc. and changed its name to NeurogesX, Inc. in September 2000. NeurogesX, Inc. was founded in 1998 and is headquartered in San Mateo, California..

Score Media Inc (NYSE:SCR) - Simcere Pharmaceutical Group develops, manufactures, and markets branded generic pharmaceuticals in the Peoples Republic of China. The companys principal branded generic pharmaceuticals include edaravone injection pharmaceutical to treat strokes under the Bicun and Yidasheng brands; amoxicillin capsules, dispersible tablets, granules, and injection under the Zailin brand; generic diclofenac sodium, an anti-inflammatory pain reliever under the Yingtaiqing brand; and sustained release implants for cancer under the Sinofuan brand. Its other branded generic pharmaceutical products comprise generic OTC anti-diarrhea pharmaceuticals under the Biqi brand; amoxicillin and clavulanate potassium tablets, granules, and injection to treat infections under the Anqi brand; cefaclor in dry suspension antibiotics for infections under the Zaike brand; and OTC herbal medicines for coughs under the Simcere Kechuanning brand name. The company also offers pharmaceuticals under various brands in the areas of antibacterial and antiviral, anti-cancer, anti-allergic, anti-osteoporosis, cardiovascular and cerebrovascular, digestive conditions, anti-inflammatory, respiratory system, urinary conditions, and vaccines. As of March 31, 2010, it had 12 product candidates in various stages of development, including treatments for cancer, cerebrovascular diseases, infections, rheumatoid arthritis, nausea, and vomiting associated with chemotherapy. The company manufactures and sells 46 pharmaceuticals and distributes 2 pharmaceuticals that are manufactured by independent third parties under its brand names. It has agreements with Epitomics, Inc. to co-develop and produce humanized RabMAb antibody therapeutics for tumors; and Advenchen to research and develop anti-cancer pharmaceuticals. The company has strategic partnerships with Sun Yat-Sen University Cancer Center and Bristol-Myers Squibb. Simcere Pharmaceutical was founded in 1995 and is headquartered in Nanjing, the Peoples Republic of China..

Exterran Holdings Inc (NYSE:EXH) - Exterran Holdings, Inc., together with its subsidiaries, provides operations, maintenance, service, and equipment for oil and natural gas industry. The companys Contract Operations segment offers natural gas compression and production, and processing services, as well as provides engineering, procurement, and on site construction of natural gas compression stations and/or crude oil or natural gas production and processing facilities. Its Aftermarket Services segment sells parts and components, and provides operation, maintenance, overhaul, and reconfiguration services. The companys Fabrication segment designs, engineers, fabricates, installs, and sells natural gas compression units and accessories; and oil and natural gas production and processing equipment designed to heat, separate, dehydrate, and condition crude oil and natural gas. Its products include line heaters, oil and natural gas separators, glycol dehydration units, dewpoint control plants, water treatment, mechanical refrigeration and cryogenic plants, and skid-mounted production packages designed for both onshore and offshore production facilities. This segment also provide engineering, procurement, and construction services primarily related to the manufacturing of process equipment for refinery and petrochemical facilities; the construction of tank farms; and the construction of evaporators and brine heaters for desalination plants. As of December 31, 2009, Exterran Holdings provided contract operations services primarily using a fleet of 10,433 natural gas compression units with an aggregate capacity of approximately 4,321,000 horsepower in North America; and a fleet of 1,164 units with an aggregate capacity of approximately 1,234,000 horsepower internationally. The company was founded in 1990 and is based in Houston, Texas..

Targacept Inc (NASDAQ:TRGT) - Targacept, Inc., a biopharmaceutical company, engages in the design, discovery, and development of novel Neuronal Nicotinic Receptors (NNR) Therapeutics for the treatment of diseases and disorders of the central nervous system. The companys pipeline of clinical-stage product candidates includes TC-5214, which completed Phase II b clinical trial for treating depressive disorders; AZD3480, which completed Phase II clinical trial in adults with attention deficit/hyperactivity disorder (ADHD) for the treatment of ADHD; AZD1446 that completed multiple Phase I trial for Alzheimers disease and ADHD; TC-5619, which is in Phase II clinical trial targeting cognitive dysfunction in schizophrenia and one or more other conditions characterized by cognitive impairment; and TC-6987, which is in Phase I trial targeting disorders characterized by inflammation. It has collaboration agreements with AstraZeneca AB for the development and commercialization of TC-5214 as a treatment for major depressive disorders; and a strategic alliance with GlaxoSmithKline to discover, develop, and market product candidates that selectively target specified NNR subtypes in specified therapeutic focus areas. The company was founded in 1997 and is based in Winston-Salem, North Carolina..

AEGON N.V. 6.875% Perpetual Capital Securities (NYSE:AEV) - AEGON N.V. 6.875% Perpetual Capital Securities.

China Housing & Land Development Inc (NASDAQ:CHLN) - China Housing & Land Development, Inc., through its subsidiaries, engages in the acquisition, development, management, and sale of commercial and residential real estate properties primarily in the western part of China. Its residential projects include multiple high-rise, middle-rise, and low-rise buildings, as well as a community center, commercial units, kindergarten, and other auxiliary facilities. The company also engages in land development activities, as well as provides property management services. Its customers primarily comprise first time home buyers and first time up-graders. The company was founded in 1992 and is headquartered in Xian, the Peoples Republic of China.. has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include: REGULATORY & COMPLIANCE NEWS Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

"Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO +1-800-715-9999 SqueezeTrigger is a registered trademark, Reg. No. 3,120,641 CONTACT: Thomas Ronk ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at on the world wide web. Inquiries to

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy